India’s Ajanta gets green light for its high blood pressure generic
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
Pharmaceuticals, Biotechnology and Life Sciences
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
BD has gotten FDA market authorization for a first-of-its-kind molecular test…
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Allergan has received approval from the FDA for Restasis, treatment to help patients with a type of Chronic Dry Eye …
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
Astellas Pharma and Pfizer have announced the FDA approved a supplemental New …
The US FDA has approved Merck’s Zinplava (bezlotoxumab) Injection 25 mg/mL, which …
Eli Lilly and Company announced that FDA has granted approval of LARTRUV (olaratumab injection, 10 mg/mL), in combination with doxorubicin, for the treatment of adults with soft tissue sarcoma (STS) with a histologic subtype for which an anthracycline-containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery.